Top Markets
#1 Tensor Tensor +34.42%
#2 Blur Blur +19.40%
#3 Ontology Gas Ontology Gas +17.50%
#4 XPIN Network XPIN Network +15.53%
#5 Dymension Dymension +14.91%
#6 Irys Irys +13.80%
#7 Corn Corn +11.17%
#8 Naoris Protocol Naoris Protocol +10.00%
#9 Tradoor Tradoor +9.51%
#10 Enjin Coin Enjin Coin +9.26%
Coin of the day
Tensor Tensor
Settings
Language
ENGLISH
Currency
USD
Theme
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Rank in Stocks #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Share Price
$0.51099792
Market Cap
$13.22M
Change (1 day)
-0.54%
Change (1 year)
99.27%
Country
SE
Trade Clinical Laserthermia Systems AB (publ) (CLS-B)

Category

Healthcare
P/E ratio for Clinical Laserthermia Systems AB (publ) (CLS-B)
P/E ratio as of April 2026 TTM: -3.33
According to Clinical Laserthermia Systems AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.33. At the end of 2023 the company had a P/E ratio of -1.16.
P/E ratio history for Clinical Laserthermia Systems AB (publ) from 2008 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -3.33 292.28%
2024 -0.85 -27.17%
2023 -1.16 15.77%
2022 -1.00 -72.89%
2021 -3.70 5.14%
2020 -3.52 -26.19%
2019 -4.77 -26.87%
2018 -6.52 -67.78%
2017 -20.25 141.77%
2016 -8.38 -21.66%
2015 -10.69 42.64%
2014 -7.50 -49.75%
2013 -14.92 -99.55%
2012 -3.35K -61.32%
2011 -8.65K -28.04%
2010 -12.02K -14.03%
2009 -13.98K 5,171.83%
2008 -265.26 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 27.47 -923.88%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 38.72 -1,261.23%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 24.08 -822.10%
IE
Medtronic Medtronic
Medtronic
MDT.US
 24.08 -822.10%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 32.19 -1,065.50%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.